Clarifying "Clear, Conspicuous and Neutral": Advertisers Will Learn New DTC Standard on the Fly
This article was originally published in RPM Report
Executive Summary
FDA's new pre-review program for direct-to-consumer ads is up and running. The agency also has a working definition for the new standard governing risk information in broadcast ads: present it the same way you do the benefits.
You may also be interested in...
DTC User Fees Shot Down; Advertisers Face More Perilous Future
The good news for advertisers: FDA will have more resources for pre-review of ads in 2008, funded by the taxpayers. The bad news: what happens in 2009?
DTC User Fees Shot Down; Advertisers Face More Perilous Future
The good news for advertisers: FDA will have more resources for pre-review of ads in 2008, funded by the taxpayers. The bad news: what happens in 2009?
The New Era in DTC: FDA Plans New Fees, Fines-and Creative Advice
The new FDA law marks a turning point in the relatively short history of direct-to-consumer broadcast ads. Sponsors have preserved the right to advertise, but will have to get used to following FDA's schedule-and taking FDA's advice.